التفاصيل البيبلوغرافية
| العنوان: |
A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. |
| المؤلفون: |
Ammar, A. S., Mahmoud, K. M., Kasemy, Z. A. |
| المصدر: |
Acta Anaesthesiologica Scandinavica; Apr2017, Vol. 61 Issue 4, p374-380, 7p, 1 Diagram, 2 Charts |
| مصطلحات موضوعية: |
NEUROMUSCULAR blocking agents, SUGAMMADEX, ABDOMINAL surgery, ROCURONIUM bromide, ANESTHETICS, PEDIATRIC intensive care, ANESTHESIA, ATROPINE, CHOLINESTERASE inhibitors, COMPARATIVE studies, CURARE-like agents, GLUCANS, RESEARCH methodology, MEDICAL cooperation, PARASYMPATHOMIMETIC agents, RESEARCH, STEROIDS, SURGICAL complications, EVALUATION research, RANDOMIZED controlled trials, TREATMENT effectiveness, MUSCARINIC antagonists, GENERAL anesthesia, CHEMICAL inhibitors |
| مستخلص: |
Background: Sugammadex is designed to be a reversal agent for steroidal muscle relaxants. The current trial was aimed to compare between sugammadex and neostigmine concerning the recovery time from neuromuscular blockade. We hypothesised that sugammadex might have shorter recovery time than neostigmine.Methods: Sixty paediatric patients aged 2-10 years scheduled for lower abdominal surgeries were randomly assigned into two equal groups to receive 4 mg/kg sugammadex (Group S) or 0.35 mg/kg neostigmine and 0.02 mg/kg atropine (Group N) as a reversal agent for rocuronium at the end of surgery. Primary outcome was the recovery time [time from starting of sugammadex or neostigmine till reaching train of four (TOF) ratio> 0.9] whereas secondary outcomes included number of patients who needed another dose of sugammadex or neostigmine to reach TOF ratio> 0.9, extubation time (time from stoppage of anaesthetic inhalation until the patient fulfilled criteria for safe extubation, post-anaesthesia care unit (PACU) discharge time and post-operative adverse effects.Results: The mean recovery and extubation times were significantly shorter (P = 0.002 and 0.005) in Group S compared with Group N (2.5 and 2.0 min vs. 12.6 min and 4.3 min respectively). In the Group N, eight patients needed another reversal dose compared with one patient in Group S (P = 0.035). PACU discharge time showed no significant difference between both groups. Incidence of nausea, vomiting, tachycardia, and dry mouth were significantly higher in Group N.Conclusion: Sugammadex administration in children resulted in faster recovery and extubation times and lower incidence of adverse events compared with neostigmine. [ABSTRACT FROM AUTHOR] |
|
Copyright of Acta Anaesthesiologica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
